NADK2 antisense RNA 1 (NADK2-AS1)

NADK2 antisense RNA 1 (NADK2-AS1) is an antisense long noncoding RNA (lncRNA) located opposite the NADK2 gene. Antisense RNAs generally function by regulating their corresponding sense transcripts, often through transcriptional interference or by modulating RNA stability, splicing, or translation. These molecules may act in cis (locally) or trans (distally) and can be challenging to study due to their overlap with sense genes. However, there is no evidence that NADK2-AS1 itself is considered a protein-coding therapeutic target, receptor, enzyme, or transporter. Instead, it should be classified as a regulatory RNA with gene modulation activity[3]. Key assessment: - The entry "NADK2 antisense RNA 1" is not a canonical drug target but rather an antisense transcript. It is not a therapeutic target such as a receptor, enzyme, transporter, or transcription factor[3]. - There is insufficient evidence for disease relevance, biomarker status, or interacting drugs for NADK2-AS1 specifically. Conventions applied: - Proper capitalization and hyphenation used. - Singular, specific name chosen. - Aliases provided. - "is_target" set to "false"; "is_incorrect" set to "true" because NADK2-AS1 is not itself a classical therapeutic target but may be relevant in gene regulation or disease context in future research. Note: If additional evidence for direct disease association or therapeutic targeting of NADK2-AS1 appears in the future, these entries should be updated accordingly. If you intended to ask about the protein-coding gene **NADK2 (NAD kinase 2, mitochondrial)**—a bona fide therapeutic target—please clarify[2][4][5][7].

Other names

NADKD1-AS1NADKD1 antisense RNA 1NADK2-AS1